Taking into consideration the interest lying in the association into a sole structure of activities directed towards both AChE and MAO-B in AD [8], we aimed at conceiving a new MTDL targeting these enzymes but contrarily to ladostigil in an indifferently manner, i.e., able to bind to each of the active site of these targets. Here, ACHE is linked to Alzheimer disease.